References
- 1. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M. Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells // J Biol Chem, 2008; 283:1026 - 1033
- 2. Heneghan HM, Miller N, Lowery AJ, Sweeney, KJ, Kerin M.J. MicroRNAs as Novel Biomarkers for Breast Cancer // J Oncol, 2010; doi: 10.1155/2010/950201
- 3. Huang GL, Zhang XH, Guo GL, Huang KT, Yang KY, Shen X, You J, Hu XQ. Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma // Oncol Rep, 2009; 21:673 -679
- 4. Huang S, He X. The role of microRNAs in liver cancer progression // Br J Cancer, 2011; 104:235 -240
- 5. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer // Cancer Res, 2005; 65:7065 - 7070
- 6. Iyevleva, A.G., Kuligina, E.Sh., Mitiushkina, N.V., Togo, A.V., Miki, Y., Imyanitov, E.N., 2011. High level of miR-21, miR-10b, and miR-31 expression in bilateral vs unilateral breast carcinomas. Breast Cancer Res. Treat. 131, 1049-1059.
- 7. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics // CA Cancer J Clin, 2011; 61:69 - 90
- 8. Ma L, Teruya-Feldstein J, Weinberg RA, et al. Tumor invasion and metastasis inhibited by microRNA-10b in breast cancer // Nature, 2007; 449:682 - 688
- 9. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Haqq C. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies // Mol Cancer, 2006: 5:24
- 10. Radojicic J, Zaravinos A, Vrekoussis T, Kafousi M, Spandidos DA, Stathopoulos EN. MicroRNA expression analysis in triple negative (ER, PR and Her2/neu) breast cancer // Cell Cycle, 2011; 10:507 -517
- 11. Sjöblom T, Jones S, Wood LD, et.al. The consensus coding sequences of human breast and colorectal cancers // Science, 2006; 314:268 - 274
- 12. Stratton MR, Campbell, PJ, Futreal PA. The cancer genome // Nature, 2009; 458:719 - 724
- 13. Toyama T, Kondo N, Endo Y, Sugiura H, Yoshimoto N, Iwasa M, Takahashi S, Fujii Y, Yamashita H. High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients // Jpn J Clin Oncol, 2012; 42:256 - 263
- 14. Valastyan S, Reinhardt F, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis // Cell, 2009; 137:1032 - 1046
- 15. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells // Nucleic Acids Res, 2009; 37:2584 - 2595
- 16. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis // RNA, 2008; 14:2348 -2360
- 17. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppresor gene tropomyosin 1 (TPM1) // J Biol Chem, 2007; 282:14328 - 14336